Re: Recurrent immune thrombocytopenic purpura in children.
Roganovic
Jelena
J
Letica-Crepulja
Marina
M
Dordevic
Luka
L
D000293:Adolescent; D000328:Adult; D002543:Cerebral Hemorrhage / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D010976:Platelet Count; D011241:Prednisone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000453:epidemiology* / Q000628:therapy; D012008:Recurrence; D012074:Remission Induction; D013156:Splenectomy
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone